Tag: Chembio Diagnostics

April 2, 2019

Chembio Diagnostics Announces Agreement with Perseus Science to Advance Point-of-Care Concussion Test

Chembio Diagnostics (NASDAQ:CEMI) has announced it has entered into an agreement with Perseus Science Group to advance developing a diagnostic...
April 25, 2018

Chembio Diagnostics and LumiraDx Enter Collaboration to Develop New Point-of-Care Diagnostic Tests for Infectious Diseases

Chembio Diagnostics (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has entered into a collaboration...
March 9, 2018

Chembio Diagnostics Reports Fourth Quarter and Full Year 2017 Financial Results

Chembio Diagnostics (Nasdaq:CEMI), a leader in point-of-care diagnostic tests for infectious diseases, today reported financial results for the fourth quarter...
February 9, 2018

Chembio Diagnostics Announces Proposed Public Offering of Common Stock

Chembio Diagnostics (NASDAQ:CEMI) a leader in point-of-care diagnostic tests for infectious diseases, announced today that it has commenced an underwritten...
May 3, 2017

Chembio Obtains Test Component Order in Brazil

Chembio Diagnostics secured a $5.8 million order from Bio-Manguinhos/Fiocruz for test components and intermediate product of DPP HIV 1/2 Assay...